Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas.
J Med Chem. 1996 Feb 16;39(4):842-9. doi: 10.1021/jm9506736.
J Med Chem. 1996.
PMID: 8632408